Table of Content
- Global Nucleic Acid-based Drugs Market Introduction and Market Overview
1.1. Objective of the Study
1.2. Global Nucleic Acid-based Drugs Market Scope and Market Estimation
1.2.1. Global Nucleic Acid-based Drugs Overall Market Size (US$ Mn), Market CAGR (%), Market forecast (2022-2030)
1.2.2. Global Nucleic Acid-based Drugs Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2022-2030
1.3. Market Segmentation
1.3.1. Type of Global Nucleic Acid-based Drugs Market
1.3.2. Application of Global Nucleic Acid-based Drugs Market
1.3.3. Sales Channel of Global Nucleic Acid-based Drugs Market
1.3.4. Region of Global Nucleic Acid-based Drugs Market
- Global Nucleic Acid-based Drugs Market - Executive Summary
2.1. Key Findings
2.1.1. Top Impacting Factors
2.1.2. Top Investment Pockets
2.1.3. Market Attractiveness Analysis
2.2. Key Companies Introduction
- Market Factor Analysis
3.1. Global Nucleic Acid-based Drugs Market Industry Development Trends under COVID-19 Outbreak
3.1.1. Global COVID-19 Status Overview
3.1.2. Influence of COVID-19 Outbreak on Global Nucleic Acid-based Drugs Market Industry Development
3.2. Market Dynamics (Growth Influencers)
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Impact Analysis of Drivers and Restraints
3.3. Ecosystem/ Value Chain Analysis
3.4. Porter’s Five Forces Analysis
3.5. SWOT Analysis
3.6. PEST Analysis
3.7. Market Opportunity Assessment – by Region (North America/ Europe/ Asia Pacific/ Middle East and Africa/ South America)
3.7.1. By Type
3.7.2. By Structure
3.7.3. By Target
3.7.4. By End Users
- Global Nucleic Acid-based Drugs Market: Estimates & Historic Trend Analysis (2017-2020)
- Global Nucleic Acid-based Drugs Market Estimates & Forecast Trend Analysis, by Type
5.1. Nucleic Acid-based Drugs Market Share (%) Estimates and Forecasts, by Type, 2022 & 2030
5.1.1. Key Market Trends, Growth Factors, and Opportunities
5.2. Nucleic Acid-based Drugs Market Revenue (US$ Mn) Estimates and Forecasts, by Type, 2017 to 2030
5.2.1. Key Market Trends, Growth Factors, and Opportunities
5.3. Anti-Sense And Anti-Gene
5.4. Short Inhibitory Sequences
5.5. Gene Transfer Therapy
5.6. Nucleoside Analogs
5.7. Ribozymes
5.8. Aptamers
- Global Nucleic Acid-based Drugs Market Estimates & Forecast Trend Analysis, by Structure
6.1. Nucleic Acid-based Drugs Market Share (%) Estimates and Forecasts, by Structure, 2022 & 2030
6.1.1. Key Market Trends, Growth Factors, and Opportunities
6.2. Nucleic Acid-based Drugs Market Revenue (US$ Mn) Estimates and Forecasts, by Structure, 2017 to 2030
6.2.1. Key Market Trends, Growth Factors, and Opportunities
6.3. Single Stranded DNA/RNA
6.4. Double Stranded DNA
6.5. Single-Stranded DNA
6.6. Others
- Global Nucleic Acid-based Drugs Market Estimates & Forecast Trend Analysis, by Target
7.1. Nucleic Acid-based Drugs Market Share (%) Estimates and Forecasts, by Target, 2022 & 2030
7.1.1. Key Market Trends, Growth Factors, and Opportunities
7.2. Nucleic Acid-based Drugs Market Revenue (US$ Mn) Estimates and Forecasts, by Target, 2017 to 2030
7.2.1. Key Market Trends, Growth Factors, and Opportunities
7.3. Transcriptor Factor
7.4. TLR9-Receptor
7.5. Protein
- Global Nucleic Acid-based Drugs Market Estimates & Forecast Trend Analysis, by End Users
8.1. Nucleic Acid-based Drugs Market Share (%) Estimates and Forecasts, by End Users, 2022 & 2030
8.1.1. Key Market Trends, Growth Factors, and Opportunities
8.2. Nucleic Acid-based Drugs Market Revenue (US$ Mn) Estimates and Forecasts, by End Users, 2017 to 2030
8.2.1. Key Market Trends, Growth Factors, and Opportunities
8.3. Hospitals
8.4. Specialty Clinics
8.5. Others
- Global Nucleic Acid-based Drugs Market Analysis and Forecast, by Region
9.1. Nucleic Acid-based Drugs Market Share (%) Estimates and Forecasts, by Region, 2022 & 2030
9.1.1. Key Market Trends, Growth Factors, and Opportunities
9.2. Nucleic Acid-based Drugs Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2017 to 2030
9.2.1. Key Market Trends, Growth Factors, and Opportunities
9.2.2. North America
9.2.3. Europe
9.2.4. Asia Pacific
9.2.5. Middle East and Africa
9.2.6. South America
- North America Nucleic Acid-based Drugs Market: Estimates & Forecast Trend Analysis
10.1. North America Market Assessments & Key Findings
10.2. North America Nucleic Acid-based Drugs Market Share (%) Estimates and Forecasts, 2022 & 2030
10.3. North America Nucleic Acid-based Drugs Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
10.3.1. By Type
10.3.2. By Structure
10.3.3. By Target
10.3.4. By End Users
10.3.5. By Country
10.3.5.1. U.S.
10.3.5.2. Canada
10.3.5.3. Mexico
- Europe Nucleic Acid-based Drugs Market: Estimates & Forecast Trend Analysis
11.1. Europe Market Assessments & Key Findings
11.2. Europe Nucleic Acid-based Drugs Market Share (%) Estimates and Forecasts, 2022 & 2030
11.3. Europe Nucleic Acid-based Drugs Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
11.3.1. By Type
11.3.2. By Structure
11.3.3. By Target
11.3.4. By End Users
11.3.5. By Country
11.3.5.1. Germany
11.3.5.2. U.K.
11.3.5.3. France
11.3.5.4. Italy
11.3.5.5. Spain
11.3.5.6. Russia
11.3.5.7. Rest of Europe
- Asia Pacific Nucleic Acid-based Drugs Market: Estimates & Forecast Trend Analysis
12.1. Asia Pacific Market Assessments & Key Findings
12.2. Asia Pacific Nucleic Acid-based Drugs Market Share (%) Estimates and Forecasts, 2022 & 2030
12.3. Asia Pacific Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
12.3.1. By Type
12.3.2. By Structure
12.3.3. By Target
12.3.4. By End Users
12.3.5. By Country
12.3.5.1. China
12.3.5.2. Japan
12.3.5.3. India
12.3.5.4. Australia
12.3.5.5. South Korea
12.3.5.6. Rest of Asia Pacific
- Middle East & Africa Nucleic Acid-based Drugs Market: Estimates & Forecast Trend Analysis
13.1. Middle East & Africa Market Assessments & Key Findings
13.2. Middle East & Africa Nucleic Acid-based Drugs Market Share (%) Estimates and Forecasts, 2022 & 2030
13.3. Middle East & Africa Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
13.3.1. By Type
13.3.2. By Structure
13.3.3. By Target
13.3.4. By End Users
13.3.5. By Country
13.3.5.1. U.A.E.
13.3.5.2. Saudi Arabia
13.3.5.3. Egypt
13.3.5.4. South Africa
13.3.5.5. Rest of Middle East & Africa
- South America Nucleic Acid-based Drugs Market: Estimates & Forecast Trend Analysis
14.1. South America Market Assessments & Key Findings
14.2. South America Nucleic Acid-based Drugs Market Share (%) Estimates and Forecasts, 2022 & 2030
14.3. South America Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
14.3.1. By Type
14.3.2. By Structure
14.3.3. By Target
14.3.4. By End Users
14.3.5. By Country
14.3.5.1. Brazil
14.3.5.2. Argentina
14.3.5.3. Colombia
14.3.5.4. Rest of South America
- Competition Landscape
15.1. Market Competition Matrix, by Leading Players
15.2. List of Emerging, Prominent and Leading Players
15.3. Major Mergers & Acquisitions, Partnership, Joint Venture, Expansions, Deals, Etc.
- Company Profiles
16.1. Wave Life Sciences
16.2. Imugene
16.3. Caperna
16.4. Phylogica
16.5. Protagonist Therapeutics
16.6. Benitec Biopharma
16.7. EGEN
16.8. BioMedica
16.9. Transgene
16.10. Nubad LLC
- Assumptions and Research Methodology
- Conclusions and Recommendations
18.1. Analysis and Suggestions on New Project Investment
18.2. Research Findings and Conclusion
List of Tables
Table1 Global Nucleic Acid-based Drugs Market Historic Analysis (US$ Mn), 2017-2021
Table2 Global Nucleic Acid-based Drugs Market Forecast Opportunity Analysis (US$ Mn), 2022-2030
Table3 Global Nucleic Acid-based Drugs Market Absolute $ Opportunity
Table4 Global Nucleic Acid-based Drugs Market Analysis by Type, 2017-2030
Table5 Global Nucleic Acid-based Drugs Market Analysis by Application, 2017-2030
Table6 Global Nucleic Acid-based Drugs Market Analysis by Region, 2017-2030
Table7 North America Nucleic Acid-based Drugs Market Absolute $ Opportunity
Table8 North America Nucleic Acid-based Drugs Market Analysis by Type, 2017-2030
Table9 North America Nucleic Acid-based Drugs Market Analysis by Application, 2017-2030
Table10 North America Nucleic Acid-based Drugs Market Analysis by Country, 2017-2030
Table11 South America Nucleic Acid-based Drugs Market Absolute $ Opportunity
Table12 South America Nucleic Acid-based Drugs Market Analysis by Type, 2017-2030
Table13 South America Nucleic Acid-based Drugs Market Analysis by Application, 2017-2030
Table14 South America Nucleic Acid-based Drugs Market Analysis by Country, 2017-2030
Table15 Europe Nucleic Acid-based Drugs Market Absolute $ Opportunity
Table16 Europe Nucleic Acid-based Drugs Market Analysis by Type, 2017-2030
Table17 Europe Nucleic Acid-based Drugs Market Analysis by Application, 2017-2030
Table18 Europe Nucleic Acid-based Drugs Market Analysis by Country, 2017-2030
Table19 Asia Pacific Nucleic Acid-based Drugs Market Absolute $ Opportunity
Table20 Asia Pacific Nucleic Acid-based Drugs Market Analysis by Type, 2017-2030
Table21 Asia Pacific Nucleic Acid-based Drugs Market Analysis by Application, 2017-2030
Table22 Asia Pacific Nucleic Acid-based Drugs Market Analysis by Country, 2017-2030
Table23 MEA Nucleic Acid-based Drugs Market Absolute $ Opportunity
Table24 MEA Nucleic Acid-based Drugs Market Analysis by Type, 2017-2030
Table25 MEA Nucleic Acid-based Drugs Market Analysis by Application, 2017-2030
Table26 MEA Nucleic Acid-based Drugs Market Analysis by Country, 2017-2030
List of Figures
Figure1 Global Nucleic Acid-based Drugs Market Historic Y-o-Y Analysis (%), 2017-2021
Figure2 Global Nucleic Acid-based Drugs Market Forecast Y-o-Y Analysis (%), 2022-2030
Figure3 Global Nucleic Acid-based Drugs Market Share Analysis by Type, 2021 and 2030
Figure4 Global Nucleic Acid-based Drugs Market Share Analysis by Application, 2021 and 2030
Figure5 Global Nucleic Acid-based Drugs Market Share Analysis by Region, 2021 and 2030
Figure6 North America Nucleic Acid-based Drugs Market Share Analysis by Type, 2021 and 2030
Figure7 North America Goods Market Share Analysis by Application, 2021 and 2030
Figure8 North America Nucleic Acid-based Drugs Market Share Analysis by Country, 2021 and 2030
Figure9 South America Nucleic Acid-based Drugs Market Share Analysis by Type, 2021 and 2030
Figure10 South America Nucleic Acid-based Drugs Market Share Analysis by Application, 2021 and 2030
Figure11 South America Nucleic Acid-based Drugs Market Share Analysis by Country, 2021 and 2030
Figure12 Europe Nucleic Acid-based Drugs Market Share Analysis by Type, 2021 and 2030
Figure13 Europe Nucleic Acid-based Drugs Market Share Analysis by Application, 2021 and 2030
Figure14 Europe Nucleic Acid-based Drugs Market Share Analysis by Country, 2021 and 2030
Figure15 Asia Pacific Nucleic Acid-based Drugs Market Share Analysis by Type, 2021 and 2030
Figure16 Asia Pacific Nucleic Acid-based Drugs Market Share Analysis by Application, 2021 and 2030
Figure17 Asia Pacific Nucleic Acid-based Drugs Market Share Analysis by Country, 2021 and 2030
Figure18 MEA Nucleic Acid-based Drugs Market Share Analysis by Type, 2021 and 2030
Figure19 MEA Nucleic Acid-based Drugs Market Share Analysis by Application, 2021 and 2030
Figure20 MEA Nucleic Acid-based Drugs Market Share Analysis by Country, 2021 and 2030
